SELLAS Life Sciences (SLS) Retained Earnings (2010 - 2026)
SELLAS Life Sciences (SLS) reported Retained Earnings of -$283.4 million for Q1 2026, down 11.62% year-over-year from -$320.7 million in Q1 2025, and down 3.06% on a QoQ basis from -$275.0 million in Q4 2025.
SELLAS Life Sciences (SLS) has 17 years of Retained Earnings data on file, last reported at -$283.4 million in Q1 2026.
- Quarterly Retained Earnings fell 11.62% year-over-year to -$283.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$283.4 million (down 11.62% YoY) and the FY2025 annual result came in at -$275.0 million, down 10.83% from the prior year.
- Retained Earnings slipped to -$283.4 million in Q1 2026 per SLS's latest filing, from -$275.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$155.3 million in Q1 2022 and bottomed at -$283.4 million in Q1 2026.
- The 5-year median for Retained Earnings is -$226.8 million (2024), against an average of -$222.2 million.
- The widest annual swing landed in 2022, when Retained Earnings sank 31.12%; it then dropped 10.73% in 2025.
- Tracing SLS's Retained Earnings over 5 years: stood at -$179.9 million in 2022, then dropped by 20.76% to -$217.2 million in 2023, then slipped by 14.21% to -$248.1 million in 2024, then retreated by 10.83% to -$275.0 million in 2025, then slipped by 3.06% to -$283.4 million in 2026.
- Per Business Quant, the three latest SLS Retained Earnings figures stand at -$283.4 million (Q1 2026), -$275.0 million (Q4 2025), and -$267.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -24.89 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | -283.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -283.40 Mn |
| Dec 31, 2025 | -274.99 Mn |
| Sep 30, 2025 | -267.30 Mn |
| Jun 30, 2025 | -260.54 Mn |
| Mar 31, 2025 | -253.90 Mn |
| Dec 31, 2024 | -248.13 Mn |
| Sep 30, 2024 | -241.40 Mn |
| Jun 30, 2024 | -234.28 Mn |
| Mar 31, 2024 | -226.80 Mn |
| Dec 31, 2023 | -217.24 Mn |
| Sep 30, 2023 | -209.10 Mn |
| Jun 30, 2023 | -199.84 Mn |
| Mar 31, 2023 | -191.00 Mn |
| Dec 31, 2022 | -179.90 Mn |
| Sep 30, 2022 | -170.80 Mn |
| Jun 30, 2022 | -163.80 Mn |
| Mar 31, 2022 | -155.35 Mn |
| Dec 31, 2021 | -138.60 Mn |
| Sep 30, 2021 | -132.00 Mn |
| Jun 30, 2021 | -124.92 Mn |
| Mar 31, 2021 | -120.31 Mn |
| Dec 31, 2020 | -117.90 Mn |
| Sep 30, 2020 | -114.19 Mn |
| Jun 30, 2020 | -109.72 Mn |
| Mar 31, 2020 | -105.30 Mn |
| Dec 31, 2019 | -101.15 Mn |
| Sep 30, 2019 | -93.73 Mn |
| Jun 30, 2019 | -89.53 Mn |
| Mar 31, 2019 | -86.39 Mn |
| Dec 31, 2018 | -81.86 Mn |
| Sep 30, 2018 | -68.53 Mn |
| Jun 30, 2018 | -68.24 Mn |
| Mar 31, 2018 | -62.18 Mn |
| Dec 31, 2017 | -54.19 Mn |
| Sep 30, 2017 | -329.13 Mn |
| Jun 30, 2017 | -323.05 Mn |
| Mar 31, 2017 | -314.65 Mn |
| Dec 31, 2016 | -30.43 Mn |
| Sep 30, 2016 | -297.42 Mn |
| Jun 30, 2016 | -290.49 Mn |
| Mar 31, 2016 | -295.88 Mn |
| Dec 31, 2015 | -279.38 Mn |
| Sep 30, 2015 | -259.71 Mn |
| Jun 30, 2015 | -241.68 Mn |
| Mar 31, 2015 | -226.02 Mn |
| Dec 31, 2014 | -215.48 Mn |
| Sep 30, 2014 | -207.53 Mn |
| Jun 30, 2014 | -201.35 Mn |
| Mar 31, 2014 | -181.41 Mn |
| Dec 31, 2013 | -178.88 Mn |
| Sep 30, 2013 | 1.72 Mn |
| Jun 30, 2013 | -121.09 Mn |
| Mar 31, 2013 | 111.49 Mn |
| Dec 31, 2012 | 1.63 Mn |
| Sep 30, 2012 | -98.45 Mn |
| Mar 31, 2012 | -91.99 Mn |
| Dec 31, 2011 | 67.23 Mn |
| Sep 30, 2011 | -68.82 Mn |
| Jun 30, 2011 | -63.34 Mn |
| Dec 31, 2010 | -55.74 Mn |